 Monitoring, Immunologic
"Monitoring, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.
| Descriptor ID |
D015166
|
| MeSH Number(s) |
E01.370.225.812.505 E01.370.520.505 E05.200.812.505 E05.478.594.550
|
| Concept/Terms |
Monitoring, Immunologic- Monitoring, Immunologic
- Immunologic Monitoring
- Monitoring, Immunological
- Immunological Monitoring
- Immune Monitoring
- Monitoring, Immune
- Immunosurveillance
Radioimmunologic Monitoring- Radioimmunologic Monitoring
- Monitoring, Radioimmunological
- Radioimmunological Monitoring
- Monitoring, Radioimmunologic
|
Below are MeSH descriptors whose meaning is more general than "Monitoring, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Monitoring, Immunologic".
This graph shows the total number of publications written about "Monitoring, Immunologic" by people in this website by year, and whether "Monitoring, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Monitoring, Immunologic" by people in Profiles.
-
Xu X, Yu Y, Zhang W, Ma W, He C, Qiu G, Wang X, Liu Q, Zhao M, Xie J, Tao F, Perry JM, Liu Q, Rao S, Kang X, Zhao M, Jiang L. SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming. Nat Cell Biol. 2024 Mar; 26(3):464-477.
-
Shakhnovich V, Meibohm B, Rosenberg A, Kierzek AM, Hasenkamp R, Funk RS, Thalhauser CJ, van der Graaf PH, Wang YC, Hamuro L. Immunogenicity in Clinical Practice and Drug Development: When is it Significant? Clin Transl Sci. 2020 03; 13(2):219-223.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|